Phase III trial of active immunotherapy (FavId (R), Id/KLH) following rituximab induction therapy: Clinical responses in patients (pts) with follicular non-Hodgkin's lymphoma (fNHL) Meeting Abstract


Authors: Freedman, A. S.; Hamlin, P. A.; Neelapu, S.; Nichols, C.; Robertson, M.; Bergier, G.; Winter, J. N.; Polikoff, J.; Lin, T.; Pohlman, B.; Esquibel, V.; Melink, T.; Bender, J.
Abstract Title: Phase III trial of active immunotherapy (FavId (R), Id/KLH) following rituximab induction therapy: Clinical responses in patients (pts) with follicular non-Hodgkin's lymphoma (fNHL)
Meeting Title: 48th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 108
Issue: 11 Pt. 1
Meeting Dates: 2006 Dec 9-12
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2006-11-01
Start Page: 780A
Language: English
ACCESSION: WOS:000242440003545
PROVIDER: wos
PUBMED: 17139767
DOI: 10.1182/blood.V108.11.2756.2756
Notes: --- - Meeting Abstract: 2756 - 48th Annual Meeting of the American-Society-of-Hematology - DEC 09-12, 2006 - Orlando, FL - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Hamlin
    277 Hamlin